| Year |
Citation |
Score |
| 2022 |
Dumas SA, Villalón E, Bergman EM, Wilson KJ, Marugan JJ, Lorson CL, Burnett BG. A combinatorial approach increases SMN level in SMA model mice. Human Molecular Genetics. PMID 35419606 DOI: 10.1093/hmg/ddac068 |
0.352 |
|
| 2022 |
Khayrullina G, Alipio-Gloria ZA, Deguise MO, Gagnon S, Chehade L, Stinson M, Belous N, Bergman EM, Lischka FW, Rotty J, Dalgard CL, Kothary R, Johnson KA, Burnett BG. Survival motor neuron protein deficiency alters microglia reactivity. Glia. PMID 35373853 DOI: 10.1002/glia.24177 |
0.339 |
|
| 2022 |
Allison RL, Welby E, Khayrullina G, Burnett BG, Ebert AD. Viral mediated knockdown of GATA6 in SMA iPSC-derived astrocytes prevents motor neuron loss and microglial activation. Glia. PMID 35088910 DOI: 10.1002/glia.24153 |
0.347 |
|
| 2021 |
McCormack NM, Villalón E, Viollet C, Soltis AR, Dalgard CL, Lorson CL, Burnett BG. Survival motor neuron deficiency slows myoblast fusion through reduced myomaker and myomixer expression. Journal of Cachexia, Sarcopenia and Muscle. PMID 34115448 DOI: 10.1002/jcsm.12740 |
0.374 |
|
| 2021 |
McCormack NM, Abera MB, Arnold ES, Gibbs RM, Martin SE, Buehler E, Chen YC, Chen L, Fischbeck KH, Burnett BG. A high-throughput genome-wide RNAi screen identifies modifiers of survival motor neuron protein. Cell Reports. 35: 109125. PMID 33979606 DOI: 10.1016/j.celrep.2021.109125 |
0.591 |
|
| 2020 |
Khayrullina G, Moritz KE, Schooley JF, Fatima N, Viollet C, McCormack NM, Smyth JT, Doughty ML, Dalgard CL, Flagg TP, Burnett BG. SMN-deficiency disrupts SERCA2 expression and intracellular Ca signaling in cardiomyocytes from SMA mice and patient-derived iPSCs. Skeletal Muscle. 10: 16. PMID 32384912 DOI: 10.1186/S13395-020-00232-7 |
0.413 |
|
| 2017 |
Rietz A, Li H, Quist KM, Cherry JJ, Lorson CL, Burnett B, Kern NL, Calder AN, Fritsche M, Lusic H, Boaler PJ, Choi S, Xing X, Glicksman MA, Cuny GD, et al. Discovery of a Small Molecule Probe that Post-translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy. Journal of Medicinal Chemistry. PMID 28481536 DOI: 10.1021/Acs.Jmedchem.6B01885 |
0.401 |
|
| 2016 |
Sangare M, Dicko I, Guinto CO, Sissoko A, Dembele K, Coulibaly Y, Coulibaly SY, Landoure G, Diallo A, Dolo M, Dolo H, Maiga B, Traore M, Karembe M, Traore K, ... ... Burnett B, et al. Does the survival motor neuron copy number variation play a role in the onset and severity of sporadic amyotrophic lateral sclerosis in Malians? Eneurologicalsci. 3: 17-20. PMID 29430530 DOI: 10.1016/J.Ensci.2015.12.001 |
0.577 |
|
| 2016 |
Abera MB, Xiao J, Nofziger J, Titus S, Southall N, Zheng W, Moritz KE, Ferrer M, Cherry JJ, Androphy EJ, Wang A, Xu X, Austin C, Fischbeck KH, Marugan JJ, ... Burnett BG, et al. ML372 blocks SMN ubiquitination and improves spinal muscular atrophy pathology in mice. Jci Insight. 1: e88427. PMID 27882347 DOI: 10.1172/Jci.Insight.88427 |
0.635 |
|
| 2016 |
Landouré G, Samassékou O, Traoré M, Meilleur KG, Guinto CO, Burnett BG, Sumner CJ, Fischbeck KH. Genetics and genomic medicine in Mali: challenges and future perspectives. Molecular Genetics & Genomic Medicine. 4: 126-134. PMID 27066513 DOI: 10.1002/Mgg3.212 |
0.456 |
|
| 2016 |
Foran E, Kwon DY, Nofziger JH, Arnold ES, Hall MD, Fischbeck KH, Burnett BG. CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: Implications for spinal muscular atrophy. Neurobiology of Disease. PMID 26792401 DOI: 10.1016/J.Nbd.2016.01.008 |
0.583 |
|
| 2016 |
Pourshafie N, Lee PR, Chen KL, Harmison GG, Bott LC, Katsuno M, Sobue G, Burnett BG, Fischbeck KH, Rinaldi C. MiR-298 Counteracts Mutant Androgen Receptor Toxicity in Spinal and Bulbar Muscular Atrophy. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 26755334 DOI: 10.1038/Mt.2016.13 |
0.564 |
|
| 2014 |
Rotimi C, Abayomi A, Abimiku A, Adabayeri VM, Adebamowo C, Adebiyi E, Ademola AD, Adeyemo A, Adu D, Affolabi D, Agongo G, Ajayi S, Akarolo-Anthony S, Akinyemi R, ... ... Burnett BG, et al. Research capacity. Enabling the genomic revolution in Africa. Science (New York, N.Y.). 344: 1346-8. PMID 24948725 DOI: 10.1126/Science.1251546 |
0.39 |
|
| 2014 |
Bricceno KV, Martinez T, Leikina E, Duguez S, Partridge TA, Chernomordik LV, Fischbeck KH, Sumner CJ, Burnett BG. Survival motor neuron protein deficiency impairs myotube formation by altering myogenic gene expression and focal adhesion dynamics. Human Molecular Genetics. 23: 4745-57. PMID 24760765 DOI: 10.1093/Hmg/Ddu189 |
0.577 |
|
| 2014 |
Sangaré M, Hendrickson B, Sango HA, Chen K, Nofziger J, Amara A, Dutra A, Schindler AB, Guindo A, Traoré M, Harmison G, Pak E, Yaro FN, Bricceno K, Grunseich C, ... ... Burnett BG, et al. Genetics of low spinal muscular atrophy carrier frequency in sub-Saharan Africa. Annals of Neurology. 75: 525-32. PMID 24515897 DOI: 10.1002/Ana.24114 |
0.581 |
|
| 2013 |
Kryndushkin D, Pripuzova N, Burnett BG, Shewmaker F. Non-targeted identification of prions and amyloid-forming proteins from yeast and mammalian cells. The Journal of Biological Chemistry. 288: 27100-11. PMID 23926098 DOI: 10.1074/Jbc.M113.485359 |
0.341 |
|
| 2013 |
Landouré G, Zhu PP, Lourenço CM, Johnson JO, Toro C, Bricceno KV, Rinaldi C, Meilleur KG, Sangaré M, Diallo O, Pierson TM, Ishiura H, Tsuji S, Hein N, Fink JK, ... ... Burnett BG, et al. Hereditary spastic paraplegia type 43 (SPG43) is caused by mutation in C19orf12. Human Mutation. 34: 1357-60. PMID 23857908 DOI: 10.1002/Humu.22378 |
0.529 |
|
| 2013 |
Kwon DY, Dimitriadi M, Terzic B, Cable C, Hart AC, Chitnis A, Fischbeck KH, Burnett BG. The E3 ubiquitin ligase mind bomb 1 ubiquitinates and promotes the degradation of survival of motor neuron protein. Molecular Biology of the Cell. 24: 1863-71. PMID 23615451 DOI: 10.1091/Mbc.E13-01-0042 |
0.63 |
|
| 2012 |
Rinaldi C, Grunseich C, Sevrioukova IF, Schindler A, Horkayne-Szakaly I, Lamperti C, Landouré G, Kennerson ML, Burnett BG, Bönnemann C, Biesecker LG, Ghezzi D, Zeviani M, Fischbeck KH. Cowchock syndrome is associated with a mutation in apoptosis-inducing factor. American Journal of Human Genetics. 91: 1095-102. PMID 23217327 DOI: 10.1016/J.Ajhg.2012.10.008 |
0.539 |
|
| 2012 |
Bricceno KV, Sampognaro PJ, Van Meerbeke JP, Sumner CJ, Fischbeck KH, Burnett BG. Histone deacetylase inhibition suppresses myogenin-dependent atrogene activation in spinal muscular atrophy mice. Human Molecular Genetics. 21: 4448-59. PMID 22798624 DOI: 10.1093/Hmg/Dds286 |
0.609 |
|
| 2012 |
Landouré G, Knight MA, Stanescu H, Taye AA, Shi Y, Diallo O, Johnson JO, Hernandez D, Traynor BJ, Biesecker LG, Elkahloun A, Rinaldi C, Vincent A, Willcox N, ... ... Burnett BG, et al. A candidate gene for autoimmune myasthenia gravis. Neurology. 79: 342-7. PMID 22744667 DOI: 10.1212/Wnl.0B013E318260Cbd0 |
0.533 |
|
| 2012 |
Landouré G, Sullivan JM, Johnson JO, Munns CH, Shi Y, Diallo O, Gibbs JR, Gaudet R, Ludlow CL, Fischbeck KH, Traynor BJ, Burnett BG, Sumner CJ. Exome sequencing identifies a novel TRPV4 mutation in a CMT2C family. Neurology. 79: 192-4. PMID 22675077 DOI: 10.1212/Wnl.0B013E31825F04B2 |
0.507 |
|
| 2012 |
Bricceno KV, Fischbeck KH, Burnett BG. Neurogenic and myogenic contributions to hereditary motor neuron disease. Neuro-Degenerative Diseases. 9: 199-209. PMID 22327341 DOI: 10.1159/000335311 |
0.593 |
|
| 2011 |
Kwon DY, Motley WW, Fischbeck KH, Burnett BG. Increasing expression and decreasing degradation of SMN ameliorate the spinal muscular atrophy phenotype in mice. Human Molecular Genetics. 20: 3667-77. PMID 21693563 DOI: 10.1093/Hmg/Ddr288 |
0.619 |
|
| 2010 |
Landouré G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Inada H, Shi Y, Taye AA, Kong L, Munns CH, Choo SS, Phelps CB, Paudel R, Houlden H, Ludlow CL, et al. Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nature Genetics. 42: 170-4. PMID 20037586 DOI: 10.1038/Ng.512 |
0.563 |
|
| 2009 |
Burnett BG, Crawford TO, Sumner CJ. Emerging treatment options for spinal muscular atrophy. Current Treatment Options in Neurology. 11: 90-101. PMID 19210911 DOI: 10.1007/S11940-009-0012-X |
0.491 |
|
| 2009 |
Kong L, Wang X, Choe DW, Polley M, Burnett BG, Bosch-Marcé M, Griffin JW, Rich MM, Sumner CJ. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 842-51. PMID 19158308 DOI: 10.1523/Jneurosci.4434-08.2009 |
0.376 |
|
| 2009 |
Burnett BG, Muñoz E, Tandon A, Kwon DY, Sumner CJ, Fischbeck KH. Regulation of SMN protein stability. Molecular and Cellular Biology. 29: 1107-15. PMID 19103745 DOI: 10.1128/Mcb.01262-08 |
0.602 |
|
| 2009 |
Ranganathan S, Harmison GG, Meyertholen K, Pennuto M, Burnett BG, Fischbeck KH. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Human Molecular Genetics. 18: 27-42. PMID 18824496 DOI: 10.1093/Hmg/Ddn310 |
0.568 |
|
| 2008 |
Narver HL, Kong L, Burnett BG, Choe DW, Bosch-Marcé M, Taye AA, Eckhaus MA, Sumner CJ. Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition. Annals of Neurology. 64: 465-70. PMID 18661558 DOI: 10.1002/Ana.21449 |
0.371 |
|
| 2008 |
Burnett BG, Andrews J, Ranganathan S, Fischbeck KH, Di Prospero NA. Expression of expanded polyglutamine targets profilin for degradation and alters actin dynamics. Neurobiology of Disease. 30: 365-74. PMID 18417352 DOI: 10.1016/J.Nbd.2008.02.007 |
0.554 |
|
| 2008 |
Burnett BG, Sumner CJ. Targeting splicing in spinal muscular atrophy. Annals of Neurology. 63: 3-6. PMID 18232015 DOI: 10.1002/Ana.21305 |
0.326 |
|
| 2007 |
Palazzolo I, Burnett BG, Young JE, Brenne PL, La Spada AR, Fischbeck KH, Howell BW, Pennuto M. Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Human Molecular Genetics. 16: 1593-603. PMID 17470458 DOI: 10.1093/Hmg/Ddm109 |
0.644 |
|
| 2007 |
Avila AM, Burnett BG, Taye AA, Gabanella F, Knight MA, Hartenstein P, Cizman Z, Di Prospero NA, Pellizzoni L, Fischbeck KH, Sumner CJ. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. The Journal of Clinical Investigation. 117: 659-71. PMID 17318264 DOI: 10.1172/Jci29562 |
0.626 |
|
| 2006 |
Bilen J, Liu N, Burnett BG, Pittman RN, Bonini NM. MicroRNA pathways modulate polyglutamine-induced neurodegeneration. Molecular Cell. 24: 157-63. PMID 17018300 DOI: 10.1016/J.Molcel.2006.07.030 |
0.489 |
|
| 2005 |
Burnett BG, Pittman RN. The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. Proceedings of the National Academy of Sciences of the United States of America. 102: 4330-5. PMID 15767577 DOI: 10.1073/Pnas.0407252102 |
0.554 |
|
| 2003 |
Burnett B, Li F, Pittman RN. The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Human Molecular Genetics. 12: 3195-205. PMID 14559776 DOI: 10.1093/Hmg/Ddg344 |
0.621 |
|
| Show low-probability matches. |